Cogent Biosciences, Inc. (COGT)

39.73 -0.44 (-1.10%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Cogent Biosciences Cash and Short Term Investments (Annual): 287.08M for Dec. 31, 2024

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Pfizer Inc. 20.48B
Ionis Pharmaceuticals, Inc. 2.303B
ADMA Biologics, Inc. 103.15M
Editas Medicine, Inc. 269.91M
AnaptysBio, Inc. 385.37M